An Investigation Into The Anti-hypertensive And Potential Anti-inflammatory Actions Of Dapagliflozin

NCT02433678 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: dapagliflozin
DRUG: Placebo

Sponsor

University at Buffalo

Collaborators

[object Object]